HPC Biosciences (Delisted) share price

BSE: 535217Agricultural Food & other Products

HPC Biosciences Limited · Face value ₹1 · Listed Mar 2013

Last traded ₹25.68 on 29 Jul 2024

Delisted on 15 Dec 2025.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.

Share price history

Daily closes since Feb 2015, adjusted for splits and bonuses. Earlier closes are left out: on 23 Feb 2015 the price changed in a way no corporate action on record explains.

Daily close, ₹ per share

Results for the half year to Sep 2021

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

Revenue
₹0.41 Cr−20.1% on a year ago · −77.1% on the half year before
Operating profit
₹0.27 Cr
Net profit
₹0.06 Cr−54.9% on a year ago · −93.9% on the half year before
Earnings per share
₹0.00
Operating margin
65.6%
Net margin
15.4%

From revenue to net profit, ₹ crore

  1. Revenue0.4
  2. Employee costs0.0
  3. Other expenses−0.1
  4. Operating profit0.3
  5. Depreciation−0.3
  6. Other income0.0
  7. Finance costs0.0
  8. Profit before tax0.1
  9. Tax0.0
  10. Net profit0.1

HPC Biosciences results by half year

Standalone: the listed company alone, without its subsidiaries. Latest half year to Sep 2021. Results for the half year to Mar 2022 were due by 30 May 2022, 60 days after it ends. Every company's dates are on the results calendar.

Revenue and net profit by half year, ₹ crore

  • Revenue
  • Net profit
1.30.7Mar 19Sep 190.80.2Mar 200.50.1Sep 201.81.0Mar 210.40.1Sep 21
Peak revenue ₹1.78 Cr, half year to Mar 2021; lowest ₹0.41 Cr, half year to Sep 2021

Operating and net margin by half year, per cent

  • Operating margin
  • Net margin
65.6%15.4%65.6%57.8%30.6%27.2%58.0%15.4%Mar 19Sep 19Mar 20Sep 20Mar 21Sep 21
₹ croreMar 2017Sep 2017Mar 2018Sep 2018Mar 2019Sep 2019Mar 2020Sep 2020Mar 2021Sep 2021
Revenue from operations1.320.711.240.331.27–0.810.511.780.41
–––0.21–––––0.14
Materials and goods bought–––0.04––0.080.00–0.00
Employee costs–––0.05–––––0.04
Other expenses–––0.12–––––0.10
Operating profit before depreciation–––0.12–––––0.27
Operating margin–––36.7%–––––65.6%
Depreciation and amortisation0.500.420.420.360.36–––0.260.25
Other income–0.060.080.080.01–0.040.030.060.05
Finance costs–––0.00––0.000.00–0.00
One-off items–––0.00––––––
Profit before tax0.410.210.13−0.160.74–0.270.141.050.06
0.01–0.040.020.00–0.020.000.020.00
Tax rate2.9%–28.0%–0.5%–8.3%0.0%2.1%0.0%
Net profit0.400.210.09−0.180.74–0.250.141.030.06
Net margin30.0%30.1%7.3%−54.8%57.8%–30.6%27.2%58.0%15.4%
Earnings per share₹0.03₹0.03₹0.01–––₹0.00––₹0.00
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the half year to Sep 2019.

HPC Biosciences results by quarter

Standalone: the listed company alone, without its subsidiaries. The quarters to Mar 2019 the company also filed in the same span.

₹ croreMar 2019
Revenue from operations1.27
0.19
Materials and goods bought0.00
Employee costs0.06
Other expenses0.13
Operating profit before depreciation1.08
Operating margin85.2%
Depreciation and amortisation0.36
Other income0.01
Finance costs0.00
One-off items0.00
Profit before tax0.74
Tax0.00
Tax rate0.5%
Net profit0.73
Net margin57.8%
Earnings per share in rupees, restated for later splits and bonuses.

9 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
4.83.0Mar 133.51.2Mar 143.30.7Mar 152.00.5Mar 162.40.5Mar 171.90.2Mar 181.60.60Mar 191.20.30Mar 202.31.2Mar 21
Peak revenue ₹4.77 Cr, year to Mar 2013; lowest ₹1.20 Cr, year to Mar 2020

Operating and net margin, per cent

  • Operating margin
  • Net margin
75.2%10.1%75.2%62.4%35.1%21.6%22.9%20.8%10.1%34.6%28.1%51.2%Mar 13Mar 15Mar 17Mar 19Mar 21

Results for the year to Mar 2021

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue2.3
  2. Depreciation−0.5
  3. Other income+0.1
  4. Profit before tax1.2
  5. Tax0.0
  6. Net profit1.2

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Sep 2021, the latest two half years added.

₹ croreMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Sep 2021Twelve months
Revenue from operations4.773.533.262.012.441.951.601.202.292.18
––––––0.40–––
Materials and goods bought––0.40–––0.040.08––
Employee costs––––––0.10–––
Other expenses––––––0.26–––
Operating profit before depreciation––––––1.20–––
Operating margin––––––75.2%–––
Materials, % of revenue––––––2.4%–––
Employee costs, % of revenue––––––6.1%–––
Other expenses, % of revenue––––––16.2%–––
Depreciation and amortisation1.331.361.411.380.990.840.72–0.510.51
Operating profit after depreciation––––––0.49–––
Other income–––––0.140.090.100.090.10
Finance costs––––––0.000.00––
One-off items––––––0.00–––
Profit before tax2.981.260.760.500.570.230.580.361.191.11
0.000.020.050.040.060.040.020.020.020.02
Net profit2.981.240.710.460.510.200.550.341.171.09
Net margin62.4%35.1%21.6%22.9%20.8%10.1%34.6%28.1%51.2%50.0%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017, Mar 2018 and Mar 2021: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2020: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2021, after the latest full year: the balance sheet at its end.

₹ croreMar 2019Mar 2020Mar 2021Sep 2021Half year
31.331.7–32.9
Share capital16.016.0–16.0
Reserves15.415.7–17.0
Borrowings0.00.0–0.0
0.60.5–0.3
Liabilities due after a year0.00.0–0.0
Total assets31.932.1–33.2
8.27.6–6.8
23.724.6–26.4
Net debt−0.3−0.3–−0.6
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the years to Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017, Mar 2018 and Mar 2021, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2021, after the latest full year: the cash flow over its six months.

₹ croreSep 2021Half year
0.28
0.33
Of which working capital0.01
Capital spending0.00
Free cash flow0.28
Cash from investing−0.07
Cash from financing0.05
Dividends paid0.00
Shares issued0.00
Net change in cash0.25
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Earnings per share₹0.03₹0.01–₹0.00–
Diluted earnings per share₹0.03₹0.01–₹0.00–
Earnings per share is left blank for the year to Mar 2019: the earnings per share is stated as 0 while the period's profit or loss comes to at least half a paisa a share, so the 0 stands in for a figure the filing does not give.

Ratios

Standalone, years to March.

RatioMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue growth−26.1%−7.4%−38.4%21.6%−20.4%−17.7%−25.0%90.6%
Net profit growth−58.5%−43.0%−34.6%10.2%−61.2%181.3%−39.3%247.6%
Earnings per share growth––––−62.5%–––
–––––1.8%1.1%–
––––––−0.7 pts–
From the net margin––––––−0.3 pts–
From asset turnover––––––−0.4 pts–
From borrowing––––––0.0 pts–
Return on capital employed–––––1.6%––
Debt to equity–––––0.000.00–
Receivable days–––––1,2081,650–
Inventory days–––––8,2103,767–
Payable days–––––0––
Cash conversion cycle, days–––––9,417––
Working capital days–––––5,2237,246–
Asset turnover–––––0.050.04–
Assets per rupee of net worth–––––1.021.02–
Sales per rupee of plant–––––0.380.33–
No balance sheet is on record for the years to Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017, Mar 2018 and Mar 2021, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2021.

Measure10 years5 years3 years
Revenue growth, yearly rate–2.6%5.5%
Profit growth, yearly rate–20.5%81.1%
Return on equity, average––1.4%
Net margin, average31.9%29.0%38.0%
Asset turnover, average––0.04
Debt to equity, average––0.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Receivables growth less revenue growthOur threshold 0 percentage points–––––––27.47–
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––––––−107.55–
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––––––1,486.77–
Effective tax ratePublished threshold 17.16 per cent0.071.596.878.7310.2715.093.986.211.85
A threshold marked as ours has no published figure; it is the line we read the check against.

Business segments

In the year to Mar 2020 the company reports one business segment, Single segment, which carries all its revenue.

HPC Biosciences share price by year

Each calendar year to 2024.

YearClose at year endChangeHighest closeLowest close
202425.68−2.0%25.6825.68
202226.20−0.9%26.7026.20
202126.45+1.9%26.4526.45
201925.95−17.5%30.8525.95
201831.45−32.4%45.6031.45
201746.50−6.1%48.5543.90
201649.50+20.7%50.5039.40
201541.00–55.1528.90
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2024 is from its first session, 29 Jul 2024. 2022 is from its first session, 28 Mar 2022. 2021 is from its first session, 26 Jul 2021. 2019 is from its first session, 17 May 2019. 2017 is from its first session, 27 Mar 2017. 2015 is from its first session, 23 Feb 2015. The change in 2024 is on the close at the end of 2022, the last year before it with a trade. The change in 2021 is on the close at the end of 2019, the last year before it with a trade. The close is the year's last trade for 2024 (29 Jul 2024), 2022 (18 Apr 2022), 2021 (26 Jul 2021), 2019 (3 Dec 2019), 2018 (28 Aug 2018), 2016 (21 Oct 2016) and 2015 (1 Oct 2015).

Recent sessions

The 10 trading days to 29 Jul 2024, as traded on BSE.

DateOpenHighLowCloseAverage priceVolume
29 Jul 202425.6825.6825.6825.6825.681,32,000
18 Apr 202226.2026.2026.2026.2026.2015,000
4 Apr 202226.7026.7026.7026.7026.7036,000
28 Mar 202226.5026.8026.5026.7026.6439,000
26 Jul 202126.4526.4526.4526.4526.4539,000
3 Dec 201925.9525.9525.9525.9525.9515,000
21 Nov 201926.4526.4526.4526.4526.4515,000
7 Nov 201926.9526.9526.9526.9526.959,000
8 Jul 201927.4527.4527.4527.4527.451,89,000
3 Jul 201928.0028.0028.0028.0028.0099,000
Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.

Ex-dateEventPrice factorWhat happened
23 Feb 2015Price move–Between two trading sessions the price fell 47% or more, or rose 90% or more. No corporate action is on record. Earlier prices are not shown.
Where an event has no factor that can be worked out, the chart leaves out the closes before it.

Company details

BSE code
535217
ISIN
INE507O01025
Industry
Agricultural Food & other Products
CIN
L24119DL2002PLC114026
Corporate identity number, the registrar of companies' code for it
Incorporated
2002
Registered office
Office No. 109, First Floor, Plot No. 22, Pooja Complex, Veer Savarkar Block, Shakarpur, New Delhi 110092, Delhi
Share registrar
Bigshare Services Pvt. Ltd
Keeps the register of shareholders and handles transfers and dividend payments